Effect of Quercetin against MES and PTZ-Induced Convulsions in Wistar Rats

Authors

  • Neeraj Choudhary Department of Pharmacognosy, ISF College of Pharmacy, Moga, Punjab, India
  • Krishna Reddy V Bijjem Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India
  • Ajudhia N. Kalia Department of Pharmacognosy, ISF College of Pharmacy, Moga, Punjab, India

Abstract


Besides its anti-oxidative effect, quercetin has shown to exert wide range of pharmacological effects. However, there is no experimental study on antiepileptic potential of quercetin. Hence, in the current study, the possible antiepileptic effect of quercetin has been evaluated against maximal electroshock seizure (MES) and PTZ-induced convulsions. Generalized tonic-clonic seizures are induced by applying current (150 mA, 0.2 s) through corneal electrodes using electroconvulsiometer. Absence seizures were induced by a single dose administration of pentylenetetrazole (PTZ); 50 mg/kg, i.p.). Neurotoxic effects were assessed by measuring locomotor activity and rotarod performance. Both single dose and one week pre-treatment with quercetin (25 and 50 mg/kg, i.p.) did not alter hindlimb extension phase, and flexion/extensor ratio in MES model. However, one week, but not single dose administration of quercetin (25 and 50 mg/kg, i.p.), significantly altered the latency to first myoclonic jerks and onset and duration of tonic generalized extensor and generalized clonic seizures in PTZ model, without producing neurotoxic effects. Thus, it may be concluded that one week treatment, but not single dose pre-treatment with quercetin produced antiepileptic effect selectively against PTZ convulsion in rats.

Keywords: Diazepam, MES, pentylenetetrazole, phenytoin, quercetin


Downloads

Published

2021-01-07

Issue

Vol. 7 No. 1 (2017)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.